Dr Lalchandani Lab Peer Comparison

BSE: 541299

₹6.89

₹-0.36 (-4.97%)

As on 30-Sep-2026IST

Market cap

₹6 Cr

Revenue (TTM)

₹4 Cr

P/E Ratio

94.5

P/B Ratio

0.4

Div. Yield

0 %

Edit

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Market cap (₹ Cr)	6	239	135	37	30
Revenue (₹ Cr)	4	57	26	17	24
Net Profit (₹ Cr)	0.42	0.15	-0.45	1.93	-3.62
Net Margin (%)	9.35	0.26	-1.72	10.69	-15.36
RoE (%)	4.29	0.26	-3.41	5.30	--
Price to Earnings	94.46	1,593.69	--	19.11	--
Price-To-Book	0.42	3.93	11.08	1.08	-11.34

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Operating Revenue	4.45	49.56	22.00	16.55	29.84
Total Income	4.46	50.86	22.39	24.55	31.18
Total Expenditure	3.53	46.00	18.47	14.69	29.92
EBITDA	0.92	3.56	3.52	1.86	-0.08
Depreciation	0.56	3.01	1.49	0.61	0.50
EBIT	0.36	0.55	2.03	1.25	-0.58
Interest	0.09	0.48	0.35	0.10	0.99
Other Income	0.01	1.30	0.39	8.00	1.35
Exceptional Items	0.12	0.01	--	--	--
Profit before Tax	0.40	1.38	2.02	9.14	-0.22
Provision for Tax	-0.02	0.64	--	1.40	-0.04
Profit after Tax	0.42	0.74	2.02	7.74	-0.19

Liabilities (₹ Cr)

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Shareholder's Funds	9.96	60.00	12.17	38.52	1.30
Minority Interest	--	--	--	--	--
Non-Current Liabilities	0.13	2.07	2.92	0.66	10.49
Current Liabilities	5.66	7.42	2.37	2.44	10.38
Total Liabilities	15.75	69.57	17.46	41.62	22.17

Assets (₹ Cr)

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Non-Current Assets	4.88	57.92	12.10	37.58	8.39
Current Assets	10.87	11.57	5.36	4.04	13.78
Total Assets	15.75	69.57	17.46	41.62	22.17
Total Debt*	4.07	0.61	1.21	1.78	10.52
Net Current Assets	5.21	4.15	2.99	1.59	3.39
Contingent Liabilities	--	0.82	1.12	0.09	0.03

Cashflow (₹ Cr)

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Cash From Operating Activities	0.37	2.70	1.83	1.81	1.47
Cash Flow from Investing Activities	0.06	-3.99	0.12	-1.23	-0.52
Cash from Financing Activities	0.58	-1.60	-0.99	-0.62	-0.24
Net Cash Inflow / Outflow	1.00	-2.89	0.95	-0.03	0.71

Ratios

Profitability Ratios

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
ROCE (%)	3.61	3.10	19.27	23.83	6.58
ROE (%)	4.29	1.24	18.13	20.73	-12.79
ROA (%)	2.71	1.09	12.57	18.98	-0.89
EBIT Margin (%)	20.90	9.81	17.79	59.58	4.24
Net Margin (%)	9.35	1.45	9.03	31.53	-0.60
Cash Profit Margin (%)	22.04	7.56	15.98	50.48	1.06

Growth Ratios

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Revenue Growth (%)	-7.40	2.81	66.60	-1.99	9.48
EBIT Growth (%)	113.93	-38.76	611.07	51.11	607.46
Net Profit Growth (%)	-32.44	-74.63	175.69	53.75	88.92
EPS Growth (%)	-32.44	-74.63	175.69	53.75	88.92
Book Value Growth (%)	4.38	1.00	19.94	6.59	-19.64

Valuation Ratios

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Price / Earnings	10.61	196.62	43.37	7.06	0.00
Price / Book Value	0.45	2.42	7.21	1.42	15.72
Dividend Yield (%)	0.00	0.00	0.00	2.15	0.00
EV/EBITDA	5.58	29.18	22.18	5.48	22.85
Market Cap (₹ Cr)	4.43	145.37	87.73	54.63	20.42

Solvency Ratios

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Debt to Equity	0.41	0.01	0.10	0.05	8.10
Short term debt to equity ratio	0.41	--	--	0.05	0.31
Current Ratio	1.92	1.56	2.26	1.65	1.33
Quick Ratio	1.69	1.04	2.05	1.56	1.24
Interest Coverage	5.71	3.88	6.82	88.23	0.78

Operating Efficiency Ratios

	Dr Lalchandani Lab	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Debtors to sales (%)	118.07	2.67	10.69	2.58	29.37
Asset Turnover	0.29	0.73	1.37	0.41	1.43
Receivable days	408.23	9.50	38.11	6.31	96.98
Inventory Days	111.84	25.93	7.95	15.24	8.69
Payable days	416.84	80.52	72.32	0.00	251.51
Cash Conversion Cycle	103.23	-45.09	-26.26	21.54	-145.84

Annual
Quarterly